(Q80562810)
Statements
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma (English)
Sattva Neelapu
Maria A Rodriguez
Fredrick Hagemeister
Peter McLaughlin
Felipe Samaniego
Nam H Dang
Jorge E Romaguara
Pamela L Walker
Michael Wang
Ann T Tong